Our findings, together with previous reports, demonstrated the regulatory effects of DKK-1 in the cancer–bone microenvironment, supported multiple roles of DKK-1 in noncanonical WNT and other signaling pathways, and indicated that DKK-1 could be a promising therapeutic target for PCa. The gene discussed is DKK1; the disease is posterior cortical atrophy.